Marc R Mansour

18PUBLICATIONS
124CO-AUTHORS
Molecular targetsHaematological tumoursRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Dec 03, 2025
Reduced PRC2 function causes asparaginase resistance in T-ALL by decreasing WNT pathway activity.

Thomas Lefeivre, Theodora-Ioana Grosu, Cosmin Tudose

|Nov 12, 2025
A non-canonical lymphoblast in refractory childhood T-cell leukaemia.

Bram S J Lim, Holly J Whitfield, Mi K Trinh

|May 20, 2025
CREBBP inactivation sensitizes B cell acute lymphoblastic leukemia to ferroptotic cell death upon BCL2 inhibition.

Alicia Garcia-Gimenez, Jonathan E Ditcham, Dhoyazan M A Azazi

|Apr 16, 2025
Elevated mitochondrial membrane potential is a therapeutic vulnerability in Dnmt3a-mutant clonal hematopoiesis.

Kira A Young, Mohsen Hosseini, Jayna J Mistry

|Apr 16, 2025
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia.

Nicola Maciocia, Malika Hoekx, Ciaran Acuna

Pageof 3